Tech Company Financing Transactions

Protez Pharmaceuticals Funding Round

Protez Pharmaceuticals, based in Malvern, secured $21 million in funding from Easton Capital.

Transaction Overview

Announced On
4/25/2006
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series B
Investors

Easton Capital (Lead Investor)

Proceeds Purpose
This additional funding from Easton and current investors will enable Protez to rapidly advance PZ-601, accelerate our research programs and increase our efforts to help the thousands of patients who face potentially life-threatening infections each year.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
30 Spring Mill Drive
Malvern, PA 19355
USA
Email Address
Overview
Protez Pharmaceuticals discovers and develops new antibiotics for difficult-to-treat infections.
Profile
Protez Pharmaceuticals LinkedIn Company Profile
Social Media
Protez Pharmaceuticals Company Twitter Account
Company News
Protez Pharmaceuticals News
Facebook
Protez Pharmaceuticals on Facebook
YouTube
Protez Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christopher Cashman
  Christopher Cashman LinkedIn Profile  Christopher Cashman Twitter Account  Christopher Cashman News  Christopher Cashman on Facebook
Chief Medical Officer
Clarence Young
  Clarence Young LinkedIn Profile  Clarence Young Twitter Account  Clarence Young News  Clarence Young on Facebook
Chief Scientific Officer
Luigi Xerri
  Luigi Xerri LinkedIn Profile  Luigi Xerri Twitter Account  Luigi Xerri News  Luigi Xerri on Facebook
Co-Founder
Klaus Esser
  Klaus Esser LinkedIn Profile  Klaus Esser Twitter Account  Klaus Esser News  Klaus Esser on Facebook
VP - R & D
Christopher Burns
  Christopher Burns LinkedIn Profile  Christopher Burns Twitter Account  Christopher Burns News  Christopher Burns on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/25/2006: Endwave venture capital transaction
Next: 4/26/2006: Olista venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary